Indaptus Therapeutics Shares Are Trading Higher After the Company Announced the Advancement of Its Phase 1 Trial for Decoy20.
Indaptus Therapeutics Shares Are Trading Higher After the Company Announced the Advancement of Its Phase 1 Trial for Decoy20.
Indaptus Therapeutics宣佈推進其Decoy20第一階段試驗後，該公司股價走高。
Indaptus Therapeutics Shares Are Trading Higher After the Company Announced the Advancement of Its Phase 1 Trial for Decoy20.
Indaptus Therapeutics宣佈推進其Decoy20第一階段試驗後，該公司股價走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。